PostEra spearheads AI-driven drug discovery collaboration to d...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BOSTON, May 19, 2022 /PRNewswire-AsiaNet/ -- PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced a multi-year collaboration with the National Institutes of Health to develop small molecule antiviral therapeutics to prevent pandemi...
Authors: LATEST ASIANET NEWS RELEASES